Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aducanumab
2
×
affordable care act
alzheimer's disease
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
deals
2
×
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
2
×
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aduro biotech
aldeyra therapeutics
What
bio
biogen’s
drug
nash
news
roundup
aducanumab
alzheimer’s
amyloid
angst
approval
bagged
billions
biogen
biopharmaceutical
brammer
companies
convo
earlier
effects
failure
failures
felt
littered
lost
new
price
remains
ripple
road
strategy
talk
week
Language
Current search:
aducanumab
×
" national top stories "
×
" seattle top stories "
×
deals
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More